Carmichael Hill & Associates, Inc. Dexcom Inc Call Options Transaction History

Carmichael Hill & Associates, Inc.

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 05, 2022	SELL	$67.99 - $132.89 $6,798 - $13,288	-100 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$94.08 - $130.2 $18,816 - $26,039	-200 Reduced 66.67%	100 $51,000
Q4 2020 Jan 27, 2021	BUY	$78.0 - $104.5 $7,800 - $10,450	100 Added 50.0%	300 $111,000
Q1 2020 May 05, 2020	BUY	$47.79 - $75.63 $9,558 - $15,126	200 New	200 $54,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Carmichael Hill & Associates, Inc., based on Form 13F filings with the SEC.

Stay updated on Carmichael Hill & Associates, Inc. with notifications on news.